OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 113 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $501 | +3.5% | 46,301 | +8.2% | 0.00% | – |
Q1 2024 | $484 | -20.5% | 42,810 | -1.4% | 0.00% | – |
Q4 2023 | $609 | +968.4% | 43,396 | +831.8% | 0.00% | – |
Q3 2023 | $57 | +18.8% | 4,657 | -13.0% | 0.00% | – |
Q2 2023 | $48 | +200.0% | 5,352 | +15.8% | 0.00% | – |
Q1 2023 | $16 | +77.8% | 4,622 | +18.3% | 0.00% | – |
Q4 2022 | $9 | -99.9% | 3,908 | -29.9% | 0.00% | – |
Q3 2022 | $16,000 | 0.0% | 5,577 | +45.7% | 0.00% | – |
Q2 2022 | $16,000 | -52.9% | 3,828 | -52.4% | 0.00% | – |
Q1 2022 | $34,000 | – | 8,040 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |